Lilly and UNICEF launch $50M push to reach 30 million children with life-saving health care
The target reach is of more than 30 million young people and caregivers across 21 countries
The target reach is of more than 30 million young people and caregivers across 21 countries
Investment to expand manufacturing and global medicine supply capacity
Olumiant is the first and only JAK inhibitor USFDA-approved for the treatment of Covid-19
Subscribe To Our Newsletter & Stay Updated